null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

Guselkumab Biosimilar (Anti-IL23A) Antibody (HDBS0146)

SKU HDBS0146
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein IL-23A
Reactivity Human
Host Species Humanized
Isotype IgG1
€431
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Guselkumab (Anti-IL23A) Biosimilar Antibody (HDBS0146)

The Guselkumab Biosimilar Anti-IL23A Antibody is a cutting-edge product designed for researchers studying interleukin-23 (IL-23) in immune regulation. This monoclonal antibody targets IL-23A, a key cytokine involved in inflammatory responses and autoimmune diseases. The antibody is produced using advanced biosimilar technology, ensuring high specificity and sensitivity in binding to IL-23A.Ideal for use in ELISA, Western blot, and immunohistochemistry applications, the Guselkumab Biosimilar Anti-IL23A Antibody enables precise detection and quantification of IL-23A in various sample types. Its unique ability to neutralize IL-23A activity makes it a valuable tool for investigating the role of IL-23A in diseases such as psoriasis, inflammatory bowel disease, and rheumatoid arthritis.

With its proven efficacy and reliability, the Guselkumab Biosimilar Anti-IL23A Antibody is a must-have for researchers seeking to deepen their understanding of IL-23A signaling pathways and develop novel therapeutic approaches targeting IL-23A-mediated immune dysregulation. Invest in this innovative antibody today and accelerate your research progress in the field of immunology and autoimmune disorders.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose